Skip to main content

Zuplenz FDA Approval History

FDA Approved: Yes (First approved July 2, 2010)
Brand name: Zuplenz
Generic name: ondansetron
Dosage form: Oral Soluble Film
Company: Strativa Pharmaceuticals
Treatment for: Nausea/Vomiting, Chemotherapy Induced, Nausea/Vomiting, Postoperative, Nausea/Vomiting, Radiation Induced

Zuplenz is an oral soluble film formulation of ondansetron for the prevention of postoperative, highly and moderately emetogenic cancer chemotherapy-induced, and radiotherapy-induced nausea and vomiting.

Development timeline for Zuplenz

Jul  5, 2010Approval FDA Approves Strativa Pharmaceuticals' Zuplenz (ondansetron) Oral Soluble Film

Further information

Always consult your healthcare provider to ensure the information displayed on this page applies to your personal circumstances.